Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2007 | 1 |
2008 | 1 |
2010 | 3 |
2011 | 3 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Hunter disease before and during enzyme replacement therapy.
Pediatr Neurol. 2011 Sep;45(3):181-4. doi: 10.1016/j.pediatrneurol.2011.05.010.
Pediatr Neurol. 2011.
PMID: 21824567
Effects of enzyme replacement therapy on growth in patients with mucopolysaccharidosis type II.
Schulze-Frenking G, Jones SA, Roberts J, Beck M, Wraith JE.
Schulze-Frenking G, et al.
J Inherit Metab Dis. 2011 Feb;34(1):203-8. doi: 10.1007/s10545-010-9215-2. Epub 2010 Oct 27.
J Inherit Metab Dis. 2011.
PMID: 20978944
Free PMC article.
Item in Clipboard
Ocular changes in patients with mucopolysaccharidosis I receiving enzyme replacement therapy: a 4-year experience.
Pitz S, Ogun O, Bajbouj M, Arash L, Schulze-Frenking G, Beck M.
Pitz S, et al. Among authors: schulze frenking g.
Arch Ophthalmol. 2007 Oct;125(10):1353-6. doi: 10.1001/archopht.125.10.1353.
Arch Ophthalmol. 2007.
PMID: 17923542
Clinical Trial.
Item in Clipboard
Importance of surgical history in diagnosing mucopolysaccharidosis type II (Hunter syndrome): data from the Hunter Outcome Survey.
Mendelsohn NJ, Harmatz P, Bodamer O, Burton BK, Giugliani R, Jones SA, Lampe C, Malm G, Steiner RD, Parini R; Hunter Outcome Survey Investigators.
Mendelsohn NJ, et al.
Genet Med. 2010 Dec;12(12):816-22. doi: 10.1097/GIM.0b013e3181f6e74d.
Genet Med. 2010.
PMID: 21045710
Free article.
Item in Clipboard
Incidence and timing of infusion-related reactions in patients with mucopolysaccharidosis type II (Hunter syndrome) on idursulfase therapy in the real-world setting: a perspective from the Hunter Outcome Survey (HOS).
Burton BK, Whiteman DA; HOS Investigators.
Burton BK, et al.
Mol Genet Metab. 2011 Jun;103(2):113-20. doi: 10.1016/j.ymgme.2011.02.018. Epub 2011 Mar 4.
Mol Genet Metab. 2011.
PMID: 21439875
Item in Clipboard
Sonographic ocular findings in patients with mucopolysaccharidoses I, II and VI.
Schumacher RG, Brzezinska R, Schulze-Frenking G, Pitz S.
Schumacher RG, et al. Among authors: schulze frenking g.
Pediatr Radiol. 2008 May;38(5):543-50. doi: 10.1007/s00247-008-0788-y. Epub 2008 Feb 26.
Pediatr Radiol. 2008.
PMID: 18299822
Item in Clipboard
Home treatment with intravenous enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II - data from the Hunter Outcome Survey.
Burton BK, Guffon N, Roberts J, van der Ploeg AT, Jones SA; HOS investigators.
Burton BK, et al.
Mol Genet Metab. 2010 Oct-Nov;101(2-3):123-9. doi: 10.1016/j.ymgme.2010.06.011. Epub 2010 Jun 23.
Mol Genet Metab. 2010.
PMID: 20638311
Item in Clipboard
Cite
Cite